Interview with Lawyer Jean-Charles Teissedre about Ivermectin
Jean-Charles Teissedre, criminal lawyer in Montpellier, recently presented a request to get the French authorities to approve a “Temporary Use Recommendation” for ivermectin, to allow
Jean-Charles Teissedre, criminal lawyer in Montpellier, recently presented a request to get the French authorities to approve a “Temporary Use Recommendation” for ivermectin, to allow
The Australian Response to COVID-19: Policies, Politics & Political Economy. An Interview with the Honorable Craig Kelly, Member of Parliament, Australia Welcome to this interview
This is the second part of our interview with the esteemed Professor Harvey Risch from Yale University. The interview, which covers a range of aspects
We are pleased to present a recording of our Oct 27 webinar with Dr Peter A. McCullough, MD, MPH, from the Baylor Heart and Vascular
We have the privilege to present you an extensive interview with Professor Harvey Risch, MD, PhD, who is Epidemiology Professor at Yale University and is
In this third and final part of our interview with Dr George Fareed, from California, you will learn about his take about: – Why large
In the second part of our interview with the esteemed Dr George Fareed, MD, we cover a range of critical questions regarding the treatment of
This is the first part of our interview with the esteemed Dr George Fareed, MD, who has treated hundreds of COVID-19 patients in California since
Dr Brian Tyson is one of the pioneers of early outpatient treatment for COVID-19, with zero death and just one short hospitalization out of some
In the second part of our interview with the esteemed Professor Thomas Borody from Australia, we discuss the question of ethical clinical trials, the progress
In this 4th and last part of our landmark interview with Professor Christian Perronne, we touch upon the following topics: The politicization of medicine Why
This is the first part of our interview with the esteemed Professor Thomas Borody, which covers the following aspects: What is the recommended ivermectin-based tri-therapy